Ji-Su Park
Directeur Général chez BSE Display
Profil
Ji-Su Park is currently the Chief Executive Officer at BSE Display and BSE Sensors Co., Ltd.
He also serves as the Chief Investment Officer at Eastbridge Partners since 2015.
Previously, he held positions as the Director, CFO, CSO & Head-Management at CoAsia Corp.
from 2011 to 2014 and as a Non-Executive Director at TCM Biosciences, Inc. Mr. Park obtained a graduate degree in MBA from The University of Chicago and an undergraduate degree from Korea University.
Postes actifs de Ji-Su Park
| Sociétés | Poste | Début |
|---|---|---|
| BSE Display | Directeur Général | - |
| BSE Sensors Co., Ltd. | Directeur Général | - |
Eastbridge Partners
 Eastbridge Partners Investment ManagersFinance Eastbridge Partners (Eastbridge Partners) is an independent private equity firm headquartered in Seoul, South Korea. The firm was founded in 2011. | Private Equity Investor | 01/01/2015 |
Anciens postes connus de Ji-Su Park
| Sociétés | Poste | Fin |
|---|---|---|
TCM Biosciences, Inc.
 TCM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology TCM Biosciences, Inc. engages in the provision of electrical diagnostic services. Its products include human papillomavirus self collection kit, sample preparation equipment, respiratory disease diagnosis, glizigen, cosmeceuticals, and medical devices. The company was founded on August 3, 2009 and is headquartered in Seongnam-si, South Korea. | Directeur/Membre du Conseil | - |
| COASIA CORPORATION | Directeur/Membre du Conseil | - |
Formation de Ji-Su Park
| The University of Chicago | Graduate Degree |
| Korea University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| COASIA CORPORATION | Electronic Technology |
| Entreprise privées | 4 |
|---|---|
| BSE Display | |
| BSE Sensors Co., Ltd. | |
Eastbridge Partners
Eastbridge Partners Investment ManagersFinance Eastbridge Partners (Eastbridge Partners) is an independent private equity firm headquartered in Seoul, South Korea. The firm was founded in 2011. | Finance |
TCM Biosciences, Inc.
TCM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology TCM Biosciences, Inc. engages in the provision of electrical diagnostic services. Its products include human papillomavirus self collection kit, sample preparation equipment, respiratory disease diagnosis, glizigen, cosmeceuticals, and medical devices. The company was founded on August 3, 2009 and is headquartered in Seongnam-si, South Korea. | Health Technology |
